Shield Therapeutics plc (AIM:STX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
7.65
-0.26 (-3.23%)
Sep 9, 2025, 2:42 PM GMT+1

Shield Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Operating Revenue
41.532.1813.095.52.0614.18
Upgrade
41.532.1813.095.52.0614.18
Upgrade
Revenue Growth (YoY)
93.23%145.93%137.95%167.36%-85.50%1389.24%
Upgrade
Cost of Revenue
21.4417.259.063.041.331.85
Upgrade
Gross Profit
20.0614.934.032.460.7312.33
Upgrade
Selling, General & Admin
32.8436.0137.9633.6527.2811.75
Upgrade
Research & Development
1.881.891.811.321.083.52
Upgrade
Other Operating Expenses
-0.05-0.1-4.41-0.86-0.15-
Upgrade
Operating Expenses
34.6737.835.3634.128.2115.27
Upgrade
Operating Income
-14.61-22.87-31.33-31.65-27.48-2.94
Upgrade
Interest Expense
-6-3.87-1.02-0.4--
Upgrade
Interest & Investment Income
0.230.270.520.040.020
Upgrade
Currency Exchange Gain (Loss)
-0.08-0.08-0.540.850.520.36
Upgrade
Other Non Operating Income (Expenses)
---0-0.08-0.01-0
Upgrade
EBT Excluding Unusual Items
-20.45-26.56-32.38-31.24-26.96-2.57
Upgrade
Asset Writedown
----18.11--
Upgrade
Pretax Income
-20.45-26.56-32.38-49.34-26.96-2.57
Upgrade
Income Tax Expense
0.790.630.920.45-0.311.02
Upgrade
Earnings From Continuing Operations
-21.24-27.18-33.29-49.79-26.65-3.59
Upgrade
Net Income
-21.24-27.18-33.29-49.79-26.65-3.59
Upgrade
Net Income to Common
-21.24-27.18-33.29-49.79-26.65-3.59
Upgrade
Shares Outstanding (Basic)
913783723233204117
Upgrade
Shares Outstanding (Diluted)
913783723233204117
Upgrade
Shares Change (YoY)
19.74%8.33%209.85%14.08%74.36%0.21%
Upgrade
EPS (Basic)
-0.02-0.03-0.05-0.21-0.13-0.03
Upgrade
EPS (Diluted)
-0.02-0.03-0.05-0.21-0.13-0.03
Upgrade
Free Cash Flow
5.05-6.81-37.37-22.66-25.23-1.91
Upgrade
Free Cash Flow Per Share
0.01-0.01-0.05-0.10-0.12-0.02
Upgrade
Gross Margin
48.34%46.39%30.78%44.70%35.48%86.96%
Upgrade
Operating Margin
-35.20%-71.08%-239.44%-575.49%-1336.01%-20.74%
Upgrade
Profit Margin
-51.18%-84.47%-254.44%-905.42%-1295.46%-25.32%
Upgrade
Free Cash Flow Margin
12.17%-21.15%-285.56%-411.98%-1226.73%-13.48%
Upgrade
EBITDA
-14.38-22.38-31.08-29.67-25.390.03
Upgrade
EBITDA Margin
-34.65%-69.56%-237.51%--0.23%
Upgrade
D&A For EBITDA
0.230.490.251.972.092.97
Upgrade
EBIT
-14.61-22.87-31.33-31.65-27.48-2.94
Upgrade
EBIT Margin
-35.20%-71.08%-239.44%---20.74%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.